Program·Company presentations
Fifteen minutes in front of investors, pharma and global business partners.
About the format
Emerging, clinical-stage and commercial-stage biotech companies present in three parallel tracks on both conference days. Each track is opened by its sponsor and runs back to back, so delegates can plan a full afternoon of presentations.
The company presentation tracks are the fastest way to see what the Swiss biotech pipeline looks like right now. Companies present their science, their value proposition and their next milestones in fifteen minutes, in a room full of investors, business development leads and industry peers.
Three tracks run in parallel: emerging biotech, clinical-stage companies and commercial-stage companies. Each track has a sponsor who opens the session, and every presenting company appears with its profile on the conference website and in the printed conference guide ahead of the event.

Why take part
The tracks draw investors, pharma business development and partnering professionals who come to scout.
Company profile, presentation title and speaker are published online and in the conference guide.
Delegates book one-on-one meetings with presenting companies directly on the partnering platform.
Last edition
More than sixty companies presented in 2026. Pureos, Celonic and Lonza sponsored the emerging, clinical-stage and commercial-stage tracks.
Monday, 14:45
Ophthanova Therapeutics
Emerging biotech track, sponsored by Pureos
Monday, 14:45
Topadur Pharma
Clinical-stage track, sponsored by Celonic
Monday, 15:00
Oculis Holding
Clinical-stage track, sponsored by Celonic
Tuesday, 13:45
AlphaMol Science
Clinical-stage track, sponsored by Celonic
Tuesday, 13:00
Akylox Therapeutics
Emerging biotech track, sponsored by Pureos
Tuesday, 13:45
Acumetis
Commercial-stage track, sponsored by Lonza
Slots are allocated in order of booking. Tell us your company stage and we will send the details.
Program